Title:
抗ＴＮＦＲ２抗体およびその使用
Document Type and Number:
Japanese Patent JP7378509
Kind Code:
B2
Abstract:
An antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors.
More Like This:
| JP2022515223 | Bifunctional molecule for human PD-1 |
| WO/2022/268192 | ANTI-CCR8 ANTIBODIES AND USES THEREOF |
| JP2023506017 | Anti-CD19 antibodies and multispecific binding proteins |
Inventors:
Chao, Xin Yan
Chao, Xiaofeng
Lu, Shiqiang
bread, orchid
Lee, Shin Shin
Ren and Chin Shon
Chao, Xiaofeng
Lu, Shiqiang
bread, orchid
Lee, Shin Shin
Ren and Chin Shon
Application Number:
JP2021578006A
Publication Date:
November 13, 2023
Filing Date:
July 31, 2020
Export Citation:
Assignee:
Chang Su Shimsar Pharmaceutical Company Limited
Simsar Bio-Pharmaceutical Technology Limited
Simsar Bio-Pharmaceutical Technology Limited
International Classes:
C12N15/13; A61K39/395; A61P35/00; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/63; G01N33/53; G01N33/531
Domestic Patent References:
| JP2018503401A |
Foreign References:
| WO2017083525A1 | ||||
| WO2017197331A2 | ||||
| WO2020102739A1 | ||||
| WO2016187068A1 |
Attorney, Agent or Firm:
Patent Attorney Corporation Taiyo International Patent Office